Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
SFDA · 77 medicines · Historical list
AEMPS · 67 medicines
AIFA · 48 medicines
CBG-MEB · 37 medicines
MS · 28 medicines · Historical list
HSA · 25 medicines
FDA · 25 medicines
ALIMS · 21 medicines
HALMED · 17 medicines
PHARMAC · 8 medicines
TFDA · 5 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
29 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ciprofloxacin | United States | 100MG, 250MG | Tablet | Marketed | Aiping Pharm INC |
| Ciprofloxacin | United States | 1200MG/120ML, 200MG/20ML, 400MG/40ML | injectable | Marketed | Hikma Farmaceutica |
| Ciprofloxacin | United States | 250MG/5ML, 500MG/5ML | for suspension | Marketed | Chartwell |
| Ciprofloxacin Hydrochloride | United States | 0.2% BASE | solution/drops | Marketed | New Heightsrx |
| Ciprofloxacin Hydrochloride | United States | 250MG BASE, 500MG BASE, 750MG BASE | tablet | Marketed | Unique |
| Ciprofloxacin Hydrochloride | United States | 0.3% BASE | solution/drops | Marketed | Pharmobedient |
| Ciprofloxacin and DexamethasoneCombination | United States | 0.3%; 0.1% | suspension/drops | Marketed | Sentiss |
| Ciprofloxacin Extended Release | United States | 212.6MG; 287.5MG BASE, 425.2MG; 574.9MG BASE | tablet, extended release | Marketed | Ani Pharms |
| Ciprofloxacin Hydrochloride and HydrocortisoneCombination | United States | 0.2% BASE; 1% | suspension/drops | Marketed | Cosette Pharms NC |
| Ciprofloxacin in Dextrose 5% in Plastic Container | United States | 200MG/100ML, 400MG/200ML | injectable | Marketed | Hikma Farmaceutica |
| Ciprofloxacin in Dextrose 5% | United States | 200MG/100ML | injectable | Not marketed | Hikma Farmaceutica |
| Cipro | United States | 250MG/5ML, 500MG/5ML | for suspension | Marketed | Bayer Hlthcare |
| Cipro | United States | 250MG BASE, 500MG BASE, 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Marketed | Bayer Hlthcare |
| Cipro HCCombination | United States | 0.2% BASE; 1% | suspension/drops | Marketed | Sandoz |
| Ciloxan | United States | 0.3% BASE | solution/drops | Marketed | Sandoz |
| Ciloxan | United States | 0.3% BASE | ointment | Marketed | Sandoz |
| Cipro XR | United States | 212.6MG; 287.5MG BASE, 212.6MG; 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 425.2MG; 574.9MG BASE … | tablet, extended release | Marketed | Bayer Hlthcare |
| CiprodexCombination | United States | 0.3%; 0.1% | suspension/drops | Marketed | Sandoz |
| Cipro | United States | 1200MG/120ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 200MG/20ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 400MG/40ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or e | injectable | Not marketed | Bayer Hlthcare |
| Cetraxal | United States | 0.2% BASE | solution/drops | Marketed | Lab Salvat |
| OtovelCombination | United States | 0.3% BASE; 0.025% | solution/drops | Marketed | Lab Salvat |
| Cipro in Dextrose 5% in Plastic Container | United States | 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable | Not marketed | Bayer Hlthcare |
| Cipro in Sodium Chloride 0.9% in Plastic Container | United States | 200MG/100ML | injectable | Not marketed | Bayer Pharms |
| Proquin XR | United States | 500MG BASE | tablet, extended release | Not marketed | Depomed INC |
| Otiprio | United States | 6% | injectable, suspension | Not marketed | Alk Abello |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
